Mancebo Victor E. 4

4 · Vireo Growth Inc. · Filed May 19, 2026

AI-generated summary of this filing

Updated May 19, 2026

Vireo Growth (VREOF) Director Victor Mancebo Receives Awards

What Happened

Victor E. Mancebo, a director of Vireo Growth Inc. (VREOF), received four derivative awards on 2026-05-15 totaling 387,675 units: 115,506; 96,859; 95,310; and 80,000. Each grant is reported at $0.00 consideration and is recorded as a derivative (options and/or RSUs) rather than an open‑market purchase.
These are compensatory awards (grants), not sales. They increase his potential future economic interest if/when options are exercised or RSUs vest and are settled.

Key Details

Transaction date: 2026-05-15; Form 4 filed 2026-05-19 (filed within the standard 2 business‑day window).
Price/consideration: $0.00 for each grant (derivative awards).
Total units granted: 387,675 (sum of 115,506 + 96,859 + 95,310 + 80,000).
Post-transaction holdings: not specified in the summary provided — see the full Form 4 for exact holdings after these grants.
Vesting and settlement notes from the filing:
- Some awards are stock options that vest in thirds (one‑third on grant, one‑third on Mar 31, 2027, and one‑third on Mar 31, 2028) or in equal annual tranches over three years.
- Some awards are restricted stock units (RSUs); RSUs vest one‑third on grant, one‑third on Mar 31, 2027, and one‑third on Mar 31, 2028, and vested RSUs will settle in cash, shares, or a combination (within 30 days after vesting).
No 10b5‑1 trading plan, tax‑withholding sale, or late filing flag is indicated in the provided summary.

Context

These grants appear to be part of director compensation (vesting scheduled over 1–3 years). Such awards are routine for insiders and do not by themselves signal a buy or sell intent. Purchases (cash outflows) are typically more informative about an insider’s market conviction.
For more detail (exact classification of each grant as option vs RSU, post‑grant ownership, or fair‑value disclosures), consult the complete Form 4 and the company’s proxy or compensation filings.

Form 4

Period: 2026-05-15

Director

Transactions

Award
Stock options (right to buy)
[F1]
2026-05-15+115,506→ 115,506 total
Exercise: $0.42Exp: 2036-05-14→ Subordinate voting shares (115,506 underlying)
Award
Restricted stock units
[F2][F3]
2026-05-15+96,859→ 96,859 total
→ Subordinate voting shares (96,859 underlying)
Award
Stock options (right to buy)
[F4]
2026-05-15+95,310→ 95,310 total
Exercise: $0.42Exp: 2036-05-14→ Subordinate voting shares (95,310 underlying)
Award
Restricted stock units
[F2][F3]
2026-05-15+80,000→ 80,000 total
→ Subordinate voting shares (80,000 underlying)

Footnotes (4)

[F1]Each stock option vests on the following schedule: one-third (1/3) of the options vest on the grant date, one-third (1/3) vest on March 31, 2027 and the remaining one-third (1/3) vest on March 31, 2028.
[F2]Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share.
[F3]The RSUs vest on the following schedule: one-third (1/3) of the RSUs vest on the grant date, one-third (1/3) vest on March 31, 2027 and the remaining one-third (1/3) vest on March 31, 2028. Vested RSUs settle in cash, subordinate voting shares, or a combination of both as soon as practicable (but not more than 30 days) following the date upon which the RSUs become vested.
[F4]Each stock option vests in equal annual tranches over a three-year period commencing on the date of grant.

Signature

/s/ Nicole A. Edmonds, Attorney-in-Fact for Victor Mancebo|2026-05-19

1 file